| Application no. and date | 19703514.0 (espacenet) (Federated) (European Patent Register), 20190116 | | Patent/reg. no. and date | DK/EP 3840753, 20240724 | | Publication date | 20210630 | | Priority no. and date | US 201862719962 P, 20180820 | | EP pub. no. and date |
EP 3840753 20210630 | | Effective date | | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | | Applicant ref. no. | 1723741 | | Inventor | BENJAMIN, Elfrida, Amicus Therapeutics, Inc., 1 Cedar Brook Drive
Cranbury, New Jersey 08512, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61P 3/00 (2006.01) | | Title | MIGALASTAT TIL ANVENDELSE I FREMGANGSMÅDER TIL BEHANDLING AF FABRYS SYGDOM HOS PATIENTER, DER HAR EN MUTATION I GLA-GENET | | Int. application no. | US2019013761 | | Int. publication no. | WO2020040806 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
